Samsung NeuroLogica and MedyMatch Technology

Announce Strategic Alliance to Bring “A.I.to the Curbside”

March 29, 2017 – Tel Aviv, Israel and Danvers, MA – MedyMatch Technology, Ltd. and Samsung NeuroLogica Corporation, the healthcare subsidiary of Samsung Electronics Co., Ltd., today announced a collaboration to integrate artificial intelligence (A.I.) clinical decision support applications with Samsung NeuroLogica’s medical imaging hardware in the acute care marketplace. This collaboration will create support tools which provide a second read capability to help caregivers quickly and accurately assess patients in prehospital environments.